Literature DB >> 7520092

Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.

J R Pollack1, D Ganem.   

Abstract

Hepatitis B viruses encode a polymerase (P) protein with key roles in both reverse transcription and genomic RNA encapsidation. Genetic analysis of cis-acting signals required for viral replication implicates an RNA stem-loop structure in both RNA packaging and the initiation of reverse transcription, a process in which P protein also serves as the primer. We now show that duck hepatitis B virus (DHBV) polymerase binds specifically and with high affinity to this RNA stem-loop structure. Mutational analysis indicates that all mutations in the RNA target that inhibit the P protein-RNA interaction inhibit both in vivo RNA packaging and in vitro DNA priming to comparable extents. However, certain mutations in the loop region of the RNA have minimal impact on P protein-RNA binding but are nonetheless severely defective for packaging and DNA synthesis. Thus, P protein-RNA complex formation is necessary but not sufficient to initiate these activities. In addition, examination of RNA binding by truncated P proteins indicates that the C terminus of the polymerase, although required for RNA encapsidation in vivo, is dispensable for RNA binding and DNA priming.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520092      PMCID: PMC236958     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

2.  5'-terminal sequences influence the segregation of ground squirrel hepatitis virus RNAs into polyribosomes and viral core particles.

Authors:  G H Enders; D Ganem; H E Varmus
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

3.  Unusual mRNA pseudoknot structure is recognized by a protein translational repressor.

Authors:  C K Tang; D E Draper
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

4.  A system for studying the selective encapsidation of hepadnavirus RNA.

Authors:  J Lavine; R Hirsch; D Ganem
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer.

Authors:  J E Tavis; S Perri; D Ganem
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA.

Authors:  R Hirsch; R Colgrove; D Ganem
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

8.  Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription.

Authors:  M Büscher; W Reiser; H Will; H Schaller
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

9.  Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts.

Authors:  C Seeger; B Baldwin; B C Tennant
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Identification of the RNA binding segment of human U1 A protein and definition of its binding site on U1 snRNA.

Authors:  D Scherly; W Boelens; W J van Venrooij; N A Dathan; J Hamm; I W Mattaj
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  100 in total

1.  Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription.

Authors:  Jeffrey W Habig; Daniel D Loeb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.

Authors:  Jianming Hu; David Toft; Dana Anselmo; Xingtai Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses.

Authors:  Xingtai Wang; Jianming Hu
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure.

Authors:  E Yao; Y Gong; N Chen; J E Tavis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.

Authors:  Xingtai Wang; Xiaofeng Qian; Hwai-Chen Guo; Jianming Hu
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90.

Authors:  J Hu; D Anselmo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus.

Authors:  Ning Liu; Lin Ji; Megan L Maguire; Daniel D Loeb
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome.

Authors:  Myeong-Kyun Shin; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Distinct requirements for primary sequence in the 5'- and 3'-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combined in vivo selection/in vitro amplification system.

Authors:  A Rieger; M Nassal
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

10.  Transfer of the minus strand of DNA during hepadnavirus replication is not invariable but prefers a specific location.

Authors:  D D Loeb; R Tian
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.